ask="22.90"
ask_size="200"
average_daily_volume="195546"
bid="21.00"
bid_size="100"
book_value="7.04"
change="-0.35"
change_from_200_day_moving_average="7.04"
change_from_50_day_moving_average="3.84"
change_from_52_week_high="-6.43"
change_From_52_week_low="10.40"
change_in_percent="-1.52%"
close="22.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18669000"
high="23.30"
high_52_weeks="29.18"
last_trade_date="1/11/2017"
last_trade_price="22.75"
last_trade_size="9662"
last_trade_time="4:00pm"
low="22.00"
low_52_weeks="12.35"
market_capitalization="648.72M"
moving_average_200_day="15.71"
moving_average_50_day="18.91"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="23.10"
pe_ratio="N/A"
peg_ratio="-0.64"
percent_change_from_200_day_moving_average="+44.81%"
percent_change_from_50_day_moving_average="+20.28%"
percent_change_from_52_week_high="-22.04%"
percent_change_from_52_week_low="+84.21%"
previous_close="23.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.28"
price_per_sales="2195.66"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="27.10"
stock_exchange="NGM"
symbol="RVNC"
volume="135578"
weeks_range_52="12.35 - 29.18"
